1. Home
  2. OR vs BRKR Comparison

OR vs BRKR Comparison

Compare OR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OR

Osisko Gold Royalties Ltd

N/A

Current Price

$42.74

Market Cap

7.5B

ML Signal

N/A

Logo Bruker Corporation

BRKR

Bruker Corporation

N/A

Current Price

$36.86

Market Cap

5.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
OR
BRKR
Founded
2014
1960
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
5.6B
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
OR
BRKR
Price
$42.74
$36.86
Analyst Decision
Hold
Buy
Analyst Count
4
13
Target Price
$38.75
$49.54
AVG Volume (30 Days)
978.1K
2.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.50%
0.55%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,895,600,000.00
Revenue This Year
$100.08
$6.27
Revenue Next Year
$13.87
$3.78
P/E Ratio
$55.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.99
$28.53
52 Week High
$48.06
$56.22

Technical Indicators

Market Signals
Indicator
OR
BRKR
Relative Strength Index (RSI) 47.64 34.77
Support Level $30.31 $35.41
Resistance Level $44.36 $37.64
Average True Range (ATR) 1.88 1.45
MACD -0.40 -0.00
Stochastic Oscillator 21.01 14.49

Price Performance

Historical Comparison
OR
BRKR

About OR Osisko Gold Royalties Ltd

OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: